Comment from Indiana University Health

Summary: Representatives from Indiana University Health, the Indiana University School of Medicine, and the Regenstrief Institute provide a detailed technical response to the FDA's Request for Information. They support the pilot program but argue that it must prioritize a multimodal data foundation, multi-step decision evaluation for agentic AI, continuous supervisory monitoring, and independent evaluation infrastructure to be successful and safe.